Table 1.
RCT characteristics and numbers of study participants and interviews
| RCT code | Clinical context | RCT type |
Clinical centres |
Interventions | Specialties involved | Primary recruiters |
Doctors, CIs or TMG |
Nurses |
Follow-up interviews |
Total number of interviews |
|---|---|---|---|---|---|---|---|---|---|---|
| n | n | n | n | n | ||||||
| T1 |
Cancer |
Feasibility |
5 |
Surgery or radiotherapy |
Surgery and oncology |
Doctors and nurses |
3 |
|
3 (1 group) |
6 |
| T2 |
Primary care and cancer |
Main |
28 |
Multiple follow-up strategies |
Primary care and oncology |
Doctors and nurses |
3 |
3 |
3 (1 group) |
9 |
| T3 |
Primary care and infection |
Main |
1 area (multiple locations) |
Drug x, drug y, drug x + y |
Primary care and paediatrics |
Nurses |
2 |
2 |
|
4 |
| T5 |
Mental health and community care |
Main |
2 areas (multiple locations) |
Specific support or usual care |
Psychiatry, community mental services |
Nurses and others |
3 |
22 (2 groups) |
2 (1 group) |
27 |
| T6 |
Cancer |
Feasibility and main |
9 |
Surgery, radiotherapy, monitoring |
Surgery and oncology |
Doctors and nurses |
13 |
10 (1 group) |
7 |
30 |
| T7 |
Cancer |
Feasibility |
22 |
Chemotherapy with surgery or with radiotherapy |
Oncology and surgery |
Doctors |
8 |
3 |
|
11 |
| Total numbers of interviews | 32 | 40 | 15 | 87 | ||||||
CI: Chief investigator; TMG: Trial management group.